LW114 Manufacturing for Phase II Clinical trial
Estimated value
£1.2m
Awarded value
£1.2m
Awarded 25 Jul 2024
Suppliers
1
Lots
1
1 awarded
Published
30 Jul 2024
Deadline 25 Jul 2024
Description
Manufacture and Supply of Phase II Clinical GMP pneumococcal protein Drug Substance and Drug Product
Scope
- Reference
- BIP872807499
- Total value
- £1,213,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2024 to 31 Aug 2025
- CPV classifications
- 33698000
Submission & procedure
- Submission deadline
- 25 Jul 2024, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£1.2m
Award date
25 Jul 2024
Contract start
31 Aug 2024
Contract end
31 Aug 2025
Awarded to
Awarded suppliers· 1 supplier
Awarded 25 Jul 2024 · Contract period 31 Aug 2024 — 31 Aug 2025
Award value
£1.2m
Other contracts from Liverpool School of Tropical Medicine
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Genibet Biopharmaceuticals· 1
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| LW114 Manufacturing for Phase II Clinical trial | contract | — | 31 Jul 2024 |